CLINICAL ROLE -
Prolia Approved by FDA for Treatment of Glucocorticoid-Induced Osteoporosis
Patients with glucocorticoid-induced osteoporosis on glucocorticoid therapy who received denosumab (Prolia) had greater gains in bone mineral density in a phase 3 trial.
Read More
Avatrombopag Tablet Approved by FDA for Patients with Chronic Liver Disease
The FDA has announced its approval of avatrombopag (Doptelet, AkaRx) tablets to treat low blood platelet count in adults with chronic liver disease.
The Wolf of Pharmacy Wall Street
Pharmacists can take working in industry to a whole new nontraditional pharmacy level by working in finance.
How an App Is Helping Independent Contractor Pharmacists in the UK Get Jobs
Locate a Locum is finding pharmacy professionals find open positions quickly.
You and Your Pharmacy Data
Pharmacies are increasingly using collected health data to target advertising to customers or identify needs and purchase patterns.
FDA Grants Breakthrough Therapy, Fast Track Designations to Narcolepsy Treatment
The FDA has granted Harmony Biosciences a Breakthrough Therapy designation for pitolisant, an investigational therapy for the treatment of cataplexy in patients with narcolepsy.
New Study Reports Mepolizumab Benefits in Severe Eosinophilic Asthma
Mepolizumab (Nucala) consistently improves exacerbation reduction and asthma control in patients with severe eosinophilic asthma.
Opioid-Related Marketing Influences Physician Prescribing Rates, Study Says
Opioid-related pharmaceutical payments were associated with an increase in the number of opioids prescribed.
Trending News Today: Obamacare Provision Tied to Earlier Cancer Detection in Young Women
Top news of the day from across the health care landscape.
Trending News Today: FDA Warns Possible Birth Defects Linked to HIV Drug
CDC Report Links Swimming-Related Disease Outbreaks to Hotel Pools
A recent CDC report demonstrates that many swimming-related disease outbreaks occur at hotel pools or hot tubs.
Simple Counseling Points for Patients Traveling Abroad
Summer vacations mean more questions on traveling. Prepare your patients with these simple tips.
Pharmacy Jobs in Unique Places, Part 2
Work all over the globe with pharmacy jobs.
4 Common Pharmacist Resume Mistakes
Your pharmacist resume is likely failing you if you aren’t hearing back from potential employers
FDA Issues Safety Alert for Drug Linked to Potential Birth Defects
Serious cases of neural tube birth defects, including spina bifida, have been reported in babies born to women with HIV being treated with dolutegravir.
Help Increasing Medication Adherence in Post-transplant Children
It is not often that we see a well-designed study integrating data collected from digital health tools, and then used by clinicians to guide care, but in this study there are some applications to pharmacy.
Trending News Today: Speaker Paul Ryan Seeks Compromise for Controversial Drug Pricing Bill
Trending News Today: FDA Calls Out Drug Makers Accused of Blocking Generics
Latest FDA Approvals Top AJPB Week in Review
Top news of the week from The American Journal of Pharmacy Benefits.
New FDA Approvals, Biosimilars Highlight SPT Week in Review
Top news of the week from Specialty Pharmacy Times.
Older Adults At Higher Risk of Continued Opioid Exposure After Hospitalization
After a hospitalization, age is positively associated with the likelihood of receiving an opioid prescription.
Novel Preventive Migraine Treatment Gains FDA Approval
Erenumab-aooe (Aimovig, Amgen) is the first FDA-approved preventive migraine treatment in a new class of drugs that work by blocking the activity of the molecule that is involved in migraine attacks.
5 Things to Do After Pharmacy Graduation
Graduating from pharmacy school is a momentous occasion. What's next?
Deprivation in COPD Linked to Increased Costs, Mortality
Deprivation in patients with chronic obstructive pulmonary disease (COPD) is associated with increased emergency healthcare use, healthcare costs, and mortality rates, according to research.
Dupilumab Shows Promise as First Biologic Treatment for Adolescents with Moderate-to-Severe Atopic Dermatitis
Dupilumab (Dupixent) significantly improved disease severity in patients aged 12 to 17 years with moderate-to-severe atopic dermatitis.
FDA Approves Preventive Migraine Treatment
First Non-Opioid Treatment for Opioid Withdrawal in Adults Gains FDA Approval
The FDA approved lofexidine hydrochloride (Lucemyra) for the mitigation of opioid withdrawal symptoms to facilitate abrupt discontinuation of opioids in adults, aged 18 and older.
President Trump's Proposed Medicare Reforms Spark Concern Among Oncologists
Community Oncology Alliance survey indicates concern that Medicare Part B reforms will have a negative effect on patient care and drive up costs.
Trending News Today: Vermont Becomes First State to Allow Imported Prescription Drugs from Canada
Novel Nasal Spray Improves Symptoms in Patients with Treatment-Resistant Depression
Data from two phase 3 studies showed that esketamine nasal spray demonstrated improvements in depressive symptoms for patients who did not respond to other antidepressant treatments.
